Vonova

2 known investors

Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull. It targets chronic neurological disorders such as chronic subdural hematomas, neuropathic pain, and epilepsy in the medical device sector.